All Posts
Evaluation and management of orthostatic hypotension: Limited data, limitless opportunity.
11 Feb, 2022 | 08:21h | UTC
ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
11 Feb, 2022 | 08:23h | UTC
Predictors and clinical outcomes of poor symptomatic improvement after transcatheter aortic valve replacement – Editorial: Transcatheter aortic valve replacement: when should we say no?
11 Feb, 2022 | 08:17h | UTCEditorial: Transcatheter aortic valve replacement: when should we say no? – openheart
M-A: Clinical outcomes and adverse events after first-line treatment in metastatic renal cell carcinoma.
11 Feb, 2022 | 08:15h | UTC
Review | Molecular imaging in oncology: Current impact and future directions.
11 Feb, 2022 | 08:12h | UTC
Arterio-Ureteral Fistula: Systematic Review of 445 Patients.
11 Feb, 2022 | 08:13h | UTCArterio-Ureteral Fistula: Systematic Review of 445 Patients – Journal of Urology
Review: Immunotherapies for hepatocellular carcinoma.
11 Feb, 2022 | 08:11h | UTCImmunotherapies for hepatocellular carcinoma – Cancer Medicine
M-A: In patients undergoing transperineal prostate biopsy, there was no significant difference in infection, fever, sepsis or readmission rates with vs. without the use of prophylactic antibiotics.
11 Feb, 2022 | 08:16h | UTC
RCT: In patients 60 years of age or older with an intracapsular hip fracture, cemented hemiarthroplasty resulted in better quality of life and lower risk of periprosthetic fracture than uncemented hemiarthroplasty.
10 Feb, 2022 | 10:19h | UTC
Commentary on Twitter
Among patients 60+ with an intracapsular hip fracture, cemented hemiarthroplasty resulted in a modestly better quality of life and a lower risk of periprosthetic fracture than uncemented hemiarthroplasty. https://t.co/BKhd0PzXDr pic.twitter.com/8fqx5HbITN
— NEJM (@NEJM) February 9, 2022
M-A: The prevalence of loneliness across 113 countries.
10 Feb, 2022 | 10:08h | UTCThe prevalence of loneliness across 113 countries: systematic review and meta-analysis – The BMJ
Editorial: We need a public health approach to loneliness
News Release: Problematic levels of loneliness widespread in many countries – BMJ
Commentary on Twitter
https://twitter.com/robert_eres/status/1491663838013702144
Clinical Review: Advances in the management of cardioembolic stroke associated with patent foramen ovale.
10 Feb, 2022 | 10:17h | UTCAdvances in the management of cardioembolic stroke associated with patent foramen ovale – The BMJ
Related:
Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases
AHA Scientific Statement: Identifying best practices to improve evaluation and management of in-hospital stroke.
10 Feb, 2022 | 10:13h | UTCNews Release: Five elements to optimize treatment of in-hospital stroke – American Heart Association
Commentary on Twitter
Identifying Best Practices to Improve Evaluation and Management of In-Hospital #Stroke: A Scientific Statement From the American Heart Association #AHAJournals #ISC22 https://t.co/e6zcLMeyBZ @American_Heart @AHAScience pic.twitter.com/eBgLc7OrBK
— Stroke AHA/ASA (@StrokeAHA_ASA) February 9, 2022
Sweden ends COVID-19 testing as pandemic restrictions lifted – “only health care and elderly care workers and the most vulnerable will be entitled to free PCR testing if they are symptomatic, while the rest of the population will simply be asked to stay home if they show symptoms that could be COVID-19”.
10 Feb, 2022 | 10:07h | UTCSweden ends COVID-19 testing as pandemic restrictions lifted – Associated Press
Related:
Covid: Europe set for ‘long period of tranquillity’ in pandemic, says WHO.
As Denmark scraps COVID restrictions, WHO urges caution.
Clinical practice guideline on tympanostomy tubes in children.
10 Feb, 2022 | 10:10h | UTC
A population-based study in Qatar showed previous infection provided robust protection against reinfection with the alpha, beta, and delta variants of SARS-CoV-2 (approximately 90%). However, protection against reinfection with the omicron variant was lower (around 60%).
10 Feb, 2022 | 10:04h | UTC
Commentary on Twitter
Using a national database in Qatar, investigators found that previous #SARSCoV2 infection provided protection against reinfection that ranged from 85% to 92% for alpha, beta, and delta strains and was approx 60% protective against omicron. #COVID19 https://t.co/SGODYCmkP3 pic.twitter.com/OkgjCbyZBj
— NEJM (@NEJM) February 9, 2022
RCT: Final analysis of efficacy and safety of single-dose J&J vaccine.
10 Feb, 2022 | 10:03h | UTCFinal Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S – New England Journal of Medicine
Commentary on Twitter
A single injection of the Ad26.COV2.S Covid-19 vaccine showed 56.3% vaccine efficacy beginning 14 days after injection and 52.9% efficacy more than 28 days after injection against moderate to severe–critical #COVID19. #IDTwitter https://t.co/0VhaEUtmwq pic.twitter.com/04QqSyYwNI
— NEJM (@NEJM) February 9, 2022
Vaccine effectiveness of heterologous CoronaVac plus Pfizer in Brazil.
10 Feb, 2022 | 10:01h | UTCVaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil – Nature Medicine
Commentary on Twitter
An analysis of data from Brazil in @NatureMedicine shows that vaccine effectiveness against SARS-CoV-2 infection and severe COVID-19 outcomes declines after two doses of CoronaVac but increases after a booster dose of the Pfizer-BioNTech vaccine. https://t.co/UCgy6cJFIP pic.twitter.com/pXvkxZHXvv
— Nature Portfolio (@NaturePortfolio) February 9, 2022
RCT: Subcutaneous Tirzepatide added to titrated Insulin Glargine improves glycemic control in patients with Type 2 Diabetes.
10 Feb, 2022 | 10:00h | UTCEffect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Tirzepatide for Patients With Type 2 Diabetes – JAMA
Commentary: SURPASS-5 Data: Tirzepatide Plus Insulin Glargine Improve Glycemic Control in T2D – AJMC
Related:
2021 Brazilian Thoracic Association recommendations for the management of severe asthma.
10 Feb, 2022 | 08:52h | UTC
Position statement on the care of the athlete and athletic person with diabetes.
10 Feb, 2022 | 08:49h | UTC
M-A: In patients with acute coronary syndrome undergoing percutaneous coronary intervention, short duration of dual antiplatelet therapy (DAPT) was comparable to de-escalation regarding all-cause death. De-escalation reduced the risk for adverse cardiovascular events, while short DAPT decreased major bleeding.
10 Feb, 2022 | 08:46h | UTCShort Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes – JACC: Cardiovascular Interventions (link to abstract – $ for full-text)
Commentary: Short Duration of DAPT vs. De-Escalation After PCI for ACS – American College of Cardiology
GOLD Report 2022: Global strategy for prevention, diagnosis and management of COPD.
10 Feb, 2022 | 08:53h | UTCGOLD Report 2022: Global strategy for prevention, diagnosis and management of COPD
Systematic Review: Overuse of diagnostic testing in healthcare.
10 Feb, 2022 | 08:47h | UTCOveruse of diagnostic testing in healthcare: a systematic review – BMJ Quality & Safety
Culprit medications and risk factors associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A population-based nested case–control study.
10 Feb, 2022 | 08:42h | UTC
M-A: Time to benefit for stroke reduction after blood pressure treatment in older adults.
10 Feb, 2022 | 08:44h | UTCNews Release: New research finds more intensive blood pressure treatment may prevent strokes in older adults – Wiley